MD, 1982, Beijing College of Chinese Medicine, Beijing, 100029 P.R. China
Research Fellow in Pathology, University of Massachusetts Medical Center, Worcester, MA
Resident in Anatomic Pathology – University of Massachusetts Medical Center, Worcester, MA
Surgical and GU Pathology Fellow, MD Anderson Cancer Center, Houston, TX
I am a surgical pathologist with a specialty in genitourinary pathology (GU) and oncological pathology. My major field of research interest is the development of biomarkers for the diagnosis and prognosis of malignant tumors. I first found P504S/a-methylacyl-CoA racemase (AMACR) to be a good diagnostic marker for prostatic adenocarcinoma in 2001 and then he published a series papers discussing the various diagnostic utilities of P504S/AMACR in prostate cancer. Now, P504S/AMACR is being widely used in clinical practice for the diagnosis of prostatic carcinoma. Furthermore, I recently discovered IMP3, an oncofetal protein, as a new prognostic biomarker for renal cell carcinoma and urothelial carcinoma. In addition, IMP3 may have potential diagnostic and prognostic values for other malignant tumors, such as gastrointestinal and gynecological cancers.